SEC Form D · filed November 6, 2020
Primmune Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (19)
Todd J. Harris · San Diego, CADirectorPaulo S. Rangel · San Diego, CAExecCharles Mcdermott · San Diego, CAExec · DirectorScott S. Morenstein · San Diego, CADirectorJames R. Appleman · San Diego, CAExec · DirectorAmir S. Nashat · SAN DIEGO, CADirectorStoyan Hadjivaltchev · New York, NYExecChristopher Mccoy · New York, NYDirectorJack Belsito · Newport Beach, CADirectorDaniel Curran · Waltham, MAExec · DirectorJames R. Appleman · San Diego, CAExec · DirectorAndrew S. Rubinstein · San Diego, CADirectorAlex Hoffman · Toronto, Ontario, CanadaExec · DirectorAngela Kattoula · Toronto, Ontario, CanadaExec · DirectorDarren Collins · Toronto, Ontario, CanadaDirectorPeter Simeon · Toronto, Ontario, CanadaExecBarry A. Kaplan · Greenwich, CTDirectorAndrew S. Rubinstein · San Diego, CADirectorAmir S. Nashat · SAN DIEGO, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗